Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Understand what expenses to consider in retirement for effective budgeting. Prepare for a financially sound future!
18,123 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Institutional moves can illuminate a stock's future. This article unpacks what it means when an investment manager be...
Copart stock dropped today after the latest earnings report, shaking up portfolios that rely on salvage auctions and ...
Two big catalysts could push XP stock higher: regulatory clarity in Brazil’s fintech scene and stronger cross-selling...
KBR faced a two-sided story: a massive backlog that hints at strong future demand, and a prominent investor trimming ...
Market dips can unlock opportunities to buy great brands at favorable prices. This guide shows how to identify stocks...
Oneok beat quarterly expectations but issued soft 2026 guidance, sending shares lower. This article explains why oneo...
The software sector has faced a sharp pullback, but not all names belong in the same bucket. This guide highlights ho...
CoreCivic has faced a share-price headwind even as revenue climbs. A notable $5 million stake by Hahn Capital signals...
Real-world assets are flowing into on-chain markets as AI-enabled DeFi trading grows. Galaxy Digital and Ondo report ...
A fresh model built on bitcoin cycle data projects forecasts a pronounced downside path for BTC, with a December 2026...
Caterpillar has powered through a demanding cycle, but can its momentum persist into 2026? This guide digs into the d...